1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Analyze DCF forecasts for the company and compare them with competitors.
1.12B
Better than MAXN's revenue of 844.84M.
No Data
No DCF data available for this metric in the selected year.
731.12M
Better than MAXN's ebitda of -46.50M.
65.00%
Better than MAXN's ebitda margin of -5.50%.
682.46M
Better than MAXN's ebit of -93.83M.
60.67%
Better than MAXN's ebit margin of -11.11%.
48.66M
Worse than MAXN's depreciation of 47.33M.
232.76M
Better than MAXN's total cash of 206.74M.
20.69%
Worse than MAXN's cash as percentage of revenue of 24.47%.
223.37M
Worse than MAXN's receivables of 102.12M.
19.86%
Worse than MAXN's receivables as percentage of revenue of 12.09%.
210.58M
Worse than MAXN's inventories of 169.24M.
18.72%
Better than MAXN's inventories as percentage of revenue of 20.03%.
166.07M
Worse than MAXN's accounts payable of 159.18M.
14.76%
Better than MAXN's payables as percentage of revenue of 18.84%.
-21.11M
Worse than MAXN's capital expenditure of -27.69M.
-1.88%
Worse than MAXN's capex as percentage of revenue of -3.28%.
7.44%
Better than MAXN's weighted average cost of capital (wacc) of 9.71%.
7.17%
Better than MAXN's cost of equity of 11.07%.
10.60%
Worse than MAXN's cost of debt of 9.70%.
0.67
Better than MAXN's beta of 1.41.
75.35M
Worse than MAXN's diluted shares outstanding of 463.87K.
153.06M
Better than MAXN's total debt of 437.66M.
125.83M
Better than MAXN's total equity of 3.01M.
278.89M
Worse than MAXN's total capital of 440.67M.
54.88%
Better than MAXN's debt weighting of 99.32%.
45.12%
Better than MAXN's equity weighting of 0.68%.
492.99M
Better than MAXN's ebiat of -102.88M.
252.66M
Better than MAXN's unlevered free cash flow of -107.83M.
1.00%
Worse than MAXN's long-term growth rate of 2.00%.
-83.85M
Better than MAXN's terminal value of -3.21B.
-47.83M
Better than MAXN's enterprise value of -2.82B.
139.68M
Better than MAXN's net debt of 247.49M.
-187.51M
Better than MAXN's equity value of -3.06B.
-2.49
Better than MAXN's equity value per share of -6606.02.
View analysts' price targets and recommendations, and compare them with competitors.
$17.50
Has upside compared to MAXN's downside of 2.34%.
Hold
Equal to MAXN's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
2.68B
No peer data available for comparison.
-145.07M
No peer data available for comparison.
-0.26
No peer data available for comparison.
-326.83M
No peer data available for comparison.
-321.54M
No peer data available for comparison.
339.56M
No peer data available for comparison.
